Implantable Biodegradable RF-Powered Tissue Stimulator and Electrodes
Implantable Biodegradable RF-Powered Tissue Stimulator and Electrodes
批准号:
8241552
负责人:
PHIL GORDON CAMPBELL
金额:
$23.22万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2013-08-31
关键词:
AddressAlloysAnimalsArtificial cardiac pacemakerBiocompatibleBody FluidsBone TissueCell ProliferationCellsChildClinicalConsultCorrosionCosmeticsCouplingDataDevelopmentDevicesDrug Delivery SystemsElectric StimulationElectrochemistryElectrodesElectronicsEvaluationExcisionFractureFrequenciesGoalsGuidelinesHistocompatibilityImageImplantIn VitroInfectionLeftLifeLife Cycle StagesMagnesiumMedical DeviceMethodsModelingMonitorMusculoskeletal PhysiologyNatural regenerationNerveNormal tissue morphologyOperative Surgical ProceduresOryctolagus cuniculusPain managementPostoperative PainPower SourcesRadioRattusResearchResourcesServicesSimulateSpinalSpinal FusionStem cellsSurgeonSystemSystems DevelopmentTechnologyTestingTherapeuticTimeTissue EngineeringTissuesTitaniaTitaniumWireless Technologybasebiomaterial compatibilitybonebone marrow stromal stem celldesignimplantable deviceimplantationin vivonovelnovel strategiesosteoblast differentiationplatinum electrodereconstructionrepairedresearch studyresponsesubcutaneoustechnology development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Implantable biodegradable electronic devices for medical applications offer the potential to provide therapeutic or monitoring functions for limited periods of time - weeks to months - degrading in register with the anticipated needs of the application and thus not requiring surgical removal. However, numerous technologies remain to be developed to enable practical biodegradable electronic systems. The goal of this R21 is to develop completely biodegradable radio frequency (RF) power generators and stimulating electrodes as novel platform technology for enabling a variety of surgically implantable biodegradable electronic devices. The generators and electrodes will be designed according to electrical specifications and forms that are compatible with their incorporation into a biodegradable spinal fusion stimulator as a paradigm application of this technology. Our novel approach will be to use RF coil circuits based on biocompatible and bioresorbable magnesium alloy conductive and resistive components, and also use this same alloy as the material for the electrodes. Using the electrical specifications of existing, non-degradable spinal fusion stimulators in clinical use for guidelines, we will design, fabricate, and test RF coil circuits and stimulating electrodes to deliver constant current stimulation. Stem cell proliferative and differentiative responses to the stimulating electrodes will be assessed in vitro and compared with responses to conventional non-degradable electrodes. Pilot experiments to assess electrode degradation and tissue compatibility will be assessed in vivo in a tethered hard-wired subcutaneous rat model. Functionality and coupling efficiency of the RF coil circuit will be assessed in vitro in simulated body fluid. Successful completion of these aims, as demonstrated by confirming predicted cellular responses and component functionalities over time, will establish the basis for follow-on research addressing component optimizations and complete system development, including integration with active electronics, and testing in an animal spinal fusion model.
PUBLIC HEALTH RELEVANCE: The objective of this study to demonstrate feasibility of key components for implantable biodegradable electronic devices that need only function temporarily, such as an electrical stimulator for spinal fusion, or in more general terms, for stimulating repair and remodeling of tissue engineered constructs, fractures, or grafts. This technology would make electrical stimulation a more practical and acceptable therapeutic option by overcoming the barriers to clinical acceptance of permanent implants that only need to function for relatively short periods of time after implantation and may require surgical removal at the end of their service life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clickable Extracellular Vesicles to Silk-Based Biomaterials for Regenerative Medicine
-
批准号:10642420
-
项目类别:
-
资助金额:$73.45万
-
财政年份:2023
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Implantable Biodegradable RF-Powered Tissue Stimulator and Electrodes
-
批准号:8327170
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2011
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Real-time computer vision tracking of stemness
-
批准号:7777326
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2007
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Real-time computer vision tracking of stemness
-
批准号:7248933
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2007
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Real-time computer vision tracking of stemness
-
批准号:7578299
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2007
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Real-time computer vision tracking of stemness
-
批准号:7413724
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2007
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Engineering Differentiation of Multi-tissue Units
-
批准号:7885831
-
项目类别:
-
资助金额:$59.16万
-
财政年份:2005
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Engineering Differentiation of Multi-tissue Units
-
批准号:8533775
-
项目类别:
-
资助金额:$51.63万
-
财政年份:2005
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Cell Response to 3D Engineered Gradients of FGF-2
-
批准号:7060419
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2005
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Cell Response to 3D Engineered Gradients of FGF-2
-
批准号:7185109
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2005
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Cell Response to 3D Engineered Gradients of FGF-2
-
批准号:6851399
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2005
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Cell Response to 3D Engineered Gradients of FGF-2
-
批准号:7367807
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2005
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Engineering Differentiation of Multi-tissue Units
-
批准号:8310186
-
项目类别:
-
资助金额:$54.83万
-
财政年份:2005
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
Engineering Differentiation of Multi-tissue Units
-
批准号:8106219
-
项目类别:
-
资助金额:$54.92万
-
财政年份:2005
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
ACCELERATING RECOVERY FROM SOFT TISSUE INJURY USING IGFI
-
批准号:6149241
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1998
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
PLASMIN SYSTEM AND IGF FUNCTION IN OSTEOSARCOMA
-
批准号:3460211
-
项目类别:
-
资助金额:$9.61万
-
财政年份:1991
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
PLASMIN SYSTEM AND IGF FUNCTION IN OSTEOSARCOMA
-
批准号:3460209
-
项目类别:
-
资助金额:$11.46万
-
财政年份:1991
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
PLASMIN SYSTEM AND IGF FUNCTION IN OSTEOSARCOMA
-
批准号:3460210
-
项目类别:
-
资助金额:$9.22万
-
财政年份:1991
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
PLASMIN SYSTEM AND IGF FUNCTION IN OSTEOSARCOMA
-
批准号:2095872
-
项目类别:
-
资助金额:$8.75万
-
财政年份:1991
-
负责人:PHIL GORDON CAMPBELL
-
依托单位:
海外基金